AbbVie to acquire Apogee for $135.11 per share in cash for total equity value of approximately $10.9 billion, positioning differentiated immunology portfolio to reach more patients worldwide Positive...
Barchart Research What to Expect from APGE Earnings APGE Generated August 7, 2026 Current Price $134.84 EPS Estimate $$-1.10 Consensus Rating Hold Average Move 4.24% Apogee Therapeutics: AbbVie's Billion-Dollar...
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti , LLC (“KSF”) are investigating the proposed sale of Apogee Therapeutics...
NEW YORK , July 14, 2026 /PRNewswire/ --
While one continues reinvesting for growth, the other has rewarded shareholders for 54 years in a row.
NEW YORK , July 6, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders...
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.
NEW YORK , July 2, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for...
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.